Baird Financial Group
PCVX icon

Baird Financial Group’s Vaxcyte PCVX Stock Holding History

Baird Financial Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$801K Hold
13,788
– – ﹤0.01% 1331
2025
Q4 		$636K Sell
13,788
-929
-6% -$41.5K ﹤0.01% 1393
2025
Q3 		$530K Buy
14,717
+418
+3% +$13.8K ﹤0.01% 1447
2025
Q2 		$465K Hold
14,299
– – ﹤0.01% 1439
2025
Q1 		$540K Buy
14,299
+2,523
+21% +$202K ﹤0.01% 1371
2024
Q4 		$964K Sell
11,776
-2,341
-17% -$232K ﹤0.01% 1191
2024
Q3 		$1.61M Sell
14,117
-5,016
-26% -$452K ﹤0.01% 1027
2024
Q2 		$1.44M Buy
19,133
+2,660
+16% +$181K ﹤0.01% 1053
2024
Q1 		$1.13M Sell
16,473
-26,984
-62% -$1.87M ﹤0.01% 1128
2023
Q4 		$2.73M Buy
+43,457
New +$2.26M 0.01% 849

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return